Skip to main content
Log in

Bariatric Surgery Is Highly Effective and Underutilized in Patients with ADHD: A 5-Year Retrospective Cohort Study

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Introduction

Obesity and ADHD have become increasingly common diagnoses. In the last decade, research has found that there is a high prevalence of obesity in patients with ADHD. The mainstays of management in the general population include lifestyle modifications, pharmacotherapies, and/or bariatric surgery. However, there is a lack of understanding of appropriate management of patients with both ADHD and obesity.

Methods

We identified those with obesity for at least five consecutive years (BMI > 30) in the TriNetX database before separating into two groups based on the presence or absence of ADHD. We assessed both the distribution of treatment modalities and the change in average BMI over time in each of our four groups across 5 years.

Results

Average BMI decreased over time in all groups, with the smallest change seen in the ADHD Pharmacology cohort (− 0.366 kg/m2) and the largest in the ADHD Surgery group (− 8.532 kg/m2). Average BMIs at the 5-year mark were significantly different.

Conclusion

Our research found that pharmacological management of individuals with ADHD was only half as effective for individuals with ADHD than our control. Though surgical management of patients with ADHD is roughly 20 times more effective in managing obesity, it was not used as frequently in comparison to medication for management of weight.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The original data presented in the study are included in the article, further inquiries can be directed to the corresponding author. The data that support the findings of this study are available from TriNetX. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from https://trinetx.com/with the permission of TriNetX.

References

  1. NHANES. Adult obesity facts CDC 2021. https://www.cdc.gov/obesity/data/adult.html. Accessed 2023.

  2. Center for Disease Control and Prevention. Prevalence of childhood obesity in the United States. CDC, 17 05 2022. https://www.cdc.gov/obesity/data/childhood.html. Accessed 24 01 2023.

  3. Body Mass Index: Considerations for Practitioners Centers for Disease Control and Prevention. Body mass index: considerations for practitioners. https://www.cdc.gov/obesity/downloads/bmiforpactitioners.pdf. Accessed 08 Sept 2023

  4. Heffron SP, Parham JS, Pendse J, et al. Treatment of obesity in mitigating metabolic risk. Circ Res. 2020;126(11):1646–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Provost DA, Malhotra S. Indications and contraindications for bariatric surgery, in The ASMBBS Textbook of Bariatric Surgery. Bariatric Surgery. 2015;1:73-76.

  6. ASMBS. Who is a candidate for bariatric surgery?. https://asmbs.org/patients/who-is-a-candidate-for-bariatric-surgery. Accessed 2023.

  7. Hampl SE, Hassink SG, Skinner AC et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Am Acad Pediatr. 2023.

  8. O’brien P, Hindle A, Brennan L. long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 200year outcomes after adjustable gastric banding,” Obes Surg. 2019;29:3-14.

  9. Xia Q, Julie AC, Ahmad H, Si L et al. Bariatric surgery is a cost-saving treatment for obesity - a comprehensive meta-analysis and updated systemic review of health economic evluations of bariatric surgery. Obes Rev. 2020;21(1).

  10. Chen M, Pan T, Hsu J et al. Risk of type 2 diabetes in adolescents and young adults with attention-deficit/hyperactivity disorder: a nationwide longitudinal study. J Clin Psychiatry, 2018;79(3).

  11. Williams A, Giust J, Kronenberger W, et al. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatr Dis Treat. 2016;12:287–96.

    PubMed  PubMed Central  Google Scholar 

  12. Gao M, Koupil I, Sjoqvist H, et al. Psychiatric comorbidity among women with endometriosis: nationwide cohort study in Sweden. Am J Obstet Gynecol. 2020;223(3):415.e1-415.e16.

    Article  PubMed  Google Scholar 

  13. National Center on Birth Defects and Developmental Disabilities. Attention deficit / hyperactivity disorder. https://www.cdc.gov/ncbddd/adhd/data.html. Accessed 08 Sept 2022

  14. Rabbitts J, Groenewald C. Epidemiology of pediatric surgery in the United States. Pediatr Anesthesiol. 2020;1083-1090.

  15. Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29:782–95.

    Article  PubMed  Google Scholar 

  16. Mohapatra S, Gangadharan K, Pitchumoni CS. Malnutrition in obesity before and after bariatric surgery. Disease-a-Month. 2020.

  17. Stenberg E, Larsson H, Marsk R, et al. Association between attention deficit hyperactivity disorder and outcomes after metabolic and bariatric surgery: a nationwide propensity-matched cohort study. Surg Obes Relat Dis : Off J Am Soc Bariatric Surg. 2023;19(2):92–100.

    Article  Google Scholar 

  18. Mocanu V, Tavakoli I, MacDonald A, et al. The impact of ADHD on outcomes following bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2019;29(4):1403–9.

    Article  PubMed  Google Scholar 

  19. Cortese S. The association between ADHD and obesity: intriguing, progressively more investigated, but still puzzling. Brain Scientific. 2019;9(10):256.

    Article  Google Scholar 

  20. Raziel A, Sakran N, Goitein D. The relationship between attention deficit hyperactivity disorders (ADHD) and obesity. Harefuah. 2014;153(9):541–55.

    PubMed  Google Scholar 

  21. Quesada D, Ahmed NU, Fennie KP, et al. A review: associations between attention-deficit/hyperactivity disorder, physical activity, medication use, eating behaviors and obesity in children and adolescents. Arch Psychiatr Nurs. 2018;32(3):495–504.

    Article  PubMed  Google Scholar 

  22. Davis C. Attention-deficit/hyperactivity disorder: associations with overeating and obesity. Current Psychiatry Rep. 2019;12(5):389–95.

    Article  Google Scholar 

  23. Lange K, Reichl S, Lange K, et al. The history of attention deficit hyperactivity disorder. Attent Deficit Hyperactive DIsorder. 2010;2(4):241–55.

    Article  Google Scholar 

  24. El AMine F, Heidinger B, Camerone JD et al. Two-month administration of methylphenidate improves olfactory sensitivity and suppresses appetite in individuals with obesity. Can J Physiol Pharmacol 2022;100(5):432-440.

  25. S. Evis, A. Cobian, H. Truong et al “Implications of multiple complications on the postoperative recovery of general surgery patients,” Annual Surgery 2016:1213-1218.

  26. Hale E, Kennis M, Yoojin Y. Post-operative complications and ADHD. Child Adolescent Psychiatry: Autism and Other Neurodevelopmental Dis. 2022.

  27. TriNetX. Publication guidelines, TriNetX. https://trinetx.com/real-world-resources/publications/trinetx-publication-guidelines/. Accessed 11 July 2022.

  28. Djalalinia S, Qorbani M, Peykari N, et al. Health impacts of obesity. Pak J Med Sci. 2015;31(1):239–42.

    PubMed  PubMed Central  Google Scholar 

  29. ASMBS. ASMBS endorsed procedures and FDA approved devices. 11 May 2022. https://asmbs.org/resources/endorsed-procedures-and-devices. Accessed 01 Sep 2023.

  30. Cortese S, Angriman M, Maffeis C, et al. Attention deficit/hyperactivity disorder (ADHD) and obestiy: a systemic review of the literature. Crit Rev Food Sci Nutr. 2008;48(6):524–37.

    Article  PubMed  Google Scholar 

  31. Gadde KM, Parker CB, Maner LG, Wagner HR. et al. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res, 2001;9(9):544-551.

  32. Wim V, Geertruida BE, Wim VdN K. Cornealis K. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2017;10

  33. Caroline MA, Louis JA, Daniel BH et al. Pharmacological management of obesity guideline resources. JCEM, 2016.

  34. Klaus L. Diet, exercise, and mental disorders - public health challenges of the future. Mov Nutr Health Dis. 2018;2:39–59.

    Google Scholar 

  35. Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010;122(1):184–91.

    Article  PubMed  Google Scholar 

  36. Yanovski S, Yanovski J. Long-term drug treatment for obesity: a systemic and clinical review. JAMA. 2014;311(1):74–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Premkumar A, Samaan JS, Samakar K. Factors associated with bariatric surgery referral patterns: a systemic review. J Surg Res. 2022;276:54–75.

    Article  PubMed  Google Scholar 

  38. Li YJ, Xie XN, Lei X et al. Global prevalence of obesity, overweight, and underweight in children, adolescents, and adults with autism spectrum disorder, attention-deficit hyperactivity disorder: a systemic review and metanalysis. Obes Rev. 2020;21(21).

  39. Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2010;316(2):104–8.

    Article  CAS  PubMed  Google Scholar 

  40. Nigg JT. Attention-deficit/hyperactivity disorder and adverse health outcomes. Clin Psychol Rev. 2013;316(2):215–28.

    Article  Google Scholar 

  41. Hegvik T, Instanes J, Haavik J, et al. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. Eur Child Adolesc Psychiatry. 2018;5(27):663–75.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kaitlyn Dickinson.

Ethics declarations

Ethics Approval and Consent to Participate

This article does not contain any studies with human participants or animals performed by any of the authors. For this type of study, formal consent is not required.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key Points

• Obesity and ADHD have become increasingly prevalent in the last few decades.

• Pharmacotherapies for obesity are only half as effective for individuals with ADHD than for individuals without ADHD in helping them lose weight.

• Patients with both ADHD and obesity who underwent surgery lost over 20 times more weight compared to the ADHD Pharmacology group; however, surgery is used only a ninth as often as medication.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 71 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dickinson, K., Parmar, P., Reyes, A.B. et al. Bariatric Surgery Is Highly Effective and Underutilized in Patients with ADHD: A 5-Year Retrospective Cohort Study. OBES SURG (2024). https://doi.org/10.1007/s11695-024-07211-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11695-024-07211-7

Keywords

Navigation